Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

KB Design & Promotion Ltd

KB Design and Promotion Limited was established in 1988, with over 20 years experience delivering global solutions for our clients.  Whilst specializing in delivering promotional products worldwide, we creatively source and supply a range of products, which promote your products.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Dice Medical Communications Logo

Dice Medical Communications

Dice Medical Communications is an independent communications agency that works with our clients to help launch, build, and continually develop great pharmaceutical brands. We do this by creating Pharmacohesion™.

View Profile

Advertising, Branding, Conference/meetings/events, Creative and design, Digital communications, Market access, Market research, Marketing consultancies, Medical communications, Medical education, Patient support and adherence, Sales, Training

- PMLiVE

Innovative Trials

Innovative Trials is a leading global clinical trial patient recruitment company. With over 10 years’ of experience, Innovative Trials deploys ‘boots-on-the-ground’ recruitment experts in over 70 countries, addressing individual sites’…

View Profile

Sales

Company Details

KB Design & Promotion Ltd
10 Foundry Court, Foundry Lane, Horsham, West Sussex, RH13 5PY, United Kingdom
+44 (0)1403 262 499
Contact KB Design & Promotion Ltd
Website

 Latest Content from PMHub 

Highlighting the Power of Patient-Integration

Press Releases | December 2, 2024 | Medscape Education

Advancing person-centered care is an important topic for the Medscape Oncology team, and no one knows this better than Dr Victoria Harvey-Jones, Associate Director of Clinical Strategy for Medscape Oncology...

Seven strategic steps to enhance patient recruitment & retention in your influenza studies

White Papers and Resources | November 29, 2024 | Innovative Trials

The development of all treatments, including vaccines, is dependent on people taking part in clinical trials but this can be challenging for influenza studies, especially given the typically short patient...

Innovating Differently: A Conversation with David W. Miller, CEO of Genesis Research Group

White Papers and Resources | November 26, 2024 | Genesis Research Group

A recent interview with Dr. David W. Miller, Chairman and CEO of Genesis Research Group, about his vision for the business, the changing face of research, and their unique value proposition...

Education, AI and More at ASH 2024

Press Releases | November 25, 2024 | Medscape Education

Medscape will showcase eight educational symposia and three posters at ASH 2024, highlighting advancements in hematology and oncology education. The presentations will reflect on the impact of last year's programs,...

Innovative Trials celebrates success for its groundbreaking Retention Patch Program

Press Releases | November 22, 2024 | Innovative Trials

Innovative Trials attended the PME Award Gala Dinner last night (21st November 2024)

Genesis Research Group unveils enhanced US market access data analytics

Press Releases | November 21, 2024 | Genesis Research Group

Genesis Research Group (“Genesis”), a pioneer of tech-enabled real-world evidence (RWE), health economics and outcomes research (HEOR), and market access services, announces the expansion of its real-world data analytics capabilities...

Stacking the odds in your favour with landscape analysis

White Papers and Resources | November 21, 2024 | Amiculum

By James Aird and Jess Choi

Health Awareness V Health Anxiety: Is the increase of online health content a help or hindrance?

White Papers and Resources | November 19, 2024 | Mednet

Medical Writer, Steph Gathercole, looks at the impact increased access to online health information has on the public through the lens of Anxiety

Insights and reflections from the Mtech Access transforming healthcare symposium

Press Releases | November 19, 2024 | Petauri Evidence

Our transforming healthcare symposium was held on Tuesday 5th November 2024. In this article, Prof Phil Richardson (Chief Innovation Officer, Mtech Access) shares his reflections from the day.

EU Joint Clinical Assessment (JCA) – Implications for Pharma and Medtech

White Papers and Resources | November 19, 2024 | Petauri Evidence

Katie Rose (Consultant – Market Access), Maria Dimitrova (Consultant – HTA) and Samantha Gillard (Director – HTA) provide an overview of the EU Joint Clinical Assessment (JCA) and what it...